1ywg Citations

Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum.

Acta Crystallogr D Biol Crystallogr 61 1213-21 (2005)
Cited: 22 times
EuropePMC logo PMID: 16131754

Abstract

The malaria parasite Plasmodium falciparum is responsible for about two million deaths annually, making it important to obtain information about enzymes from this organism that represent potential drug targets. The gene for P. falciparum glyceraldehyde-3-phosphate dehydrogenase (PfGAPDH) has been cloned and the protein expressed as a hexahistidine-tagged recombinant protein in Escherichia coli. The recombinant protein has been crystallized and its three-dimensional structure determined. One molecule of the cofactor NAD+ is bound to each of the four subunits in the tetrameric enzyme. The major structural feature distinguishing human GAPDH from PfGAPDH is the insertion of a dipeptide (-KG-) in the so-called S loop. This insert, together with other characteristic single-amino-acid substitutions, alters the chemical environment of the groove that encompasses the R dyad and that links adjacent cofactor-binding sites and may be responsible for the selective inhibition of the enzyme by ferriprotoporphyrin IX.

Reviews - 1ywg mentioned but not cited (2)

Articles - 1ywg mentioned but not cited (7)

  1. Structure of RdxA--an oxygen-insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori. Martínez-Júlvez M, Rojas AL, Olekhnovich I, Espinosa Angarica V, Hoffman PS, Sancho J. FEBS J 279 4306-4317 (2012)
  2. Brazilian malaria molecular targets (BraMMT): selected receptors for virtual high-throughput screening experiments. Nunes RR, Fonseca ALD, Pinto ACS, Maia EHB, Silva AMD, Varotti FP, Taranto AG. Mem Inst Oswaldo Cruz 114 e180465 (2019)
  3. Structure of Streptococcus agalactiae glyceraldehyde-3-phosphate dehydrogenase holoenzyme reveals a novel surface. Ayres CA, Schormann N, Senkovich O, Fry A, Banerjee S, Ulett GC, Chattopadhyay D. Acta Crystallogr F Struct Biol Commun 70 1333-1339 (2014)
  4. Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro. Cullia G, Bruno S, Parapini S, Margiotta M, Tamborini L, Pinto A, Galbiati A, Mozzarelli A, Persico M, Paladino A, Fattorusso C, Taramelli D, Conti P. ACS Med Chem Lett 10 590-595 (2019)
  5. Dehydrobufotenin extracted from the Amazonian toad Rhinella marina (Anura: Bufonidae) as a prototype molecule for the development of antiplasmodial drugs. Banfi FF, Krombauer GC, da Fonseca AL, Nunes RR, Andrade SN, de Rezende MA, Chaves MH, Monção EDS, Taranto AG, Rodrigues DJ, Vieira GM, de Castro WV, Varotti FP, Sanchez BAM. J Venom Anim Toxins Incl Trop Dis 27 e20200073 (2021)
  6. In vitro and in silico assessment of new beta amino ketones with antiplasmodial activity. Krombauer GC, Guedes KS, Banfi FF, Nunes RR, Fonseca ALD, Siqueira EP, Bellei JCB, Scopel KKG, Varotti FP, Sanchez BAM. Rev Soc Bras Med Trop 55 e0590 (2022)
  7. The search for molecular mimicry in proteins carried by extracellular vesicles secreted by cells infected with Plasmodium falciparum. Armijos-Jaramillo V, Mosquera A, Rojas B, Tejera E. Commun Integr Biol 14 212-220 (2021)


Articles citing this publication (13)

  1. Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Bhowmick IP, Kumar N, Sharma S, Coppens I, Jarori GK. Malar J 8 179 (2009)
  2. Specific expression and export of the Plasmodium falciparum Gametocyte EXported Protein-5 marks the gametocyte ring stage. Tibúrcio M, Dixon MW, Looker O, Younis SY, Tilley L, Alano P. Malar J 14 334 (2015)
  3. Tracking Glideosome-associated protein 50 reveals the development and organization of the inner membrane complex of Plasmodium falciparum. Yeoman JA, Hanssen E, Maier AG, Klonis N, Maco B, Baum J, Turnbull L, Whitchurch CB, Dixon MW, Tilley L. Eukaryot Cell 10 556-564 (2011)
  4. Plasmodium glyceraldehyde-3-phosphate dehydrogenase: A potential malaria diagnostic target. Krause RGE, Hurdayal R, Choveaux D, Przyborski JM, Coetzer THT, Goldring JPD. Exp Parasitol 179 7-19 (2017)
  5. In silico prediction of antimalarial drug target candidates. Ludin P, Woodcroft B, Ralph SA, Mäser P. Int J Parasitol Drugs Drug Resist 2 191-199 (2012)
  6. Crystal Structure of Glyceraldehyde-3-Phosphate Dehydrogenase from the Gram-Positive Bacterial Pathogen A. vaginae, an Immunoevasive Factor that Interacts with the Human C5a Anaphylatoxin. Querol-García J, Fernández FJ, Marin AV, Gómez S, Fullà D, Melchor-Tafur C, Franco-Hidalgo V, Albertí S, Juanhuix J, Rodríguez de Córdoba S, Regueiro JR, Vega MC. Front Microbiol 8 541 (2017)
  7. Effect of 3-bromopyruvate and atovaquone on infection during in vitro interaction of Toxoplasma gondii and LLC-MK2 cells. de Lima LP, Seabra SH, Carneiro H, Barbosa HS. Antimicrob Agents Chemother 59 5239-5249 (2015)
  8. Membrane skeletal association and post-translational allosteric regulation of Toxoplasma gondii GAPDH1. Dubey R, Staker BL, Foe IT, Bogyo M, Myler PJ, Ngô HM, Gubbels MJ. Mol Microbiol 103 618-634 (2017)
  9. Biochemical characterisation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from the liver fluke, Fasciola hepatica. Zinsser VL, Hoey EM, Trudgett A, Timson DJ. Biochim Biophys Acta 1844 744-749 (2014)
  10. Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund's and Pheroid® Adjuvants. Krause RG, Grobler AF, Goldring JP. Immunol Invest 44 627-642 (2015)
  11. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: implications for structure-based drug design. Kundu S, Roy D. J Biomol Struct Dyn 25 25-33 (2007)
  12. Phylogenetic and structural information on glyceraldehyde-3-phosphate dehydrogenase (G3PDH) in Plasmodium provides functional insights. Akinyi S, Gaona J, Meyer EV, Barnwell JW, Galinski MR, Corredor V. Infect Genet Evol 8 205-212 (2008)
  13. A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery. Yerlikaya S, Owusu EDA, Frimpong A, DeLisle RK, Ding XC. Clin Infect Dis 74 40-51 (2022)